LAMEA Apheresis Market Size, Trends & Growth to 2022-2028

LAMEA Apheresis Market Size, Share & Industry Trends Analysis Report By Procedure (Donor/Automated and Therapeutic), By Product, By Method, By End User, By Component, By Country and Growth Forecast, 2022 - 2028

Published Date: June-2022 | Number of Pages: 118 | Format: PDF | Report ID: KBV-18518

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the LAMEA Apheresis Market

Market Report Description

The Latin America, Middle East and Africa Apheresis Market would witness market growth of 11.1% CAGR during the forecast period (2022-2028).

A unit of whole blood is collected from a donor and sent to a research lab, where it is isolated into its four components such as red blood cells, white blood cells, platelets, and plasma – in traditional blood donation. The components are stashed and relying on the medical need are administered to patients following surgery, an accident, illness, or chemotherapy.

Whereas the donor is still attached to the separation device, apheresis separates the blood into these components. The donor's whole blood is separated into components based on density using a rotating centrifuge or a rotating belt.

The apheresis operator instructs the required component into a storage container using sterile equipment; the others return to the donor via a syringe inserted into a vein in the arm. In some cases, blood is collected and returned via a central line, which is an invasive procedure implanted into a vein in the upper shoulder.

The South African National Blood Service offers a hybrid therapeutic apheresis service that includes mobile and fixed-site apheresis, as well as an apheresis harvest of hematopoietic stem cells (HPC-A). Plasmapheresis, red cell exchange, and leukocyte and platelet reductions are among the therapeutic apheresis methods offered by SANBS. Additionally, apheresis is used to collect plasma, thrombocytes, mononuclear cells, including CD34+ cells (HPCs), and granulocytes for plasma and cellular therapies, as well as personalized apheresis products for research.

Since the 1970s, therapeutic plasma exchange has been utilised to treat immune-mediated illnesses. However, evidence outside the therapeutic indication is still anecdotal, relying on observed data and national registries from around the community. The original goal was to look at how therapeutic plasma exchange (TPE) was used to treat various illnesses in the Dubai Hospital's nephrology department and compare it to the American Society of Apheresis' (ASFA) standard indications categories.

The Brazil market dominated the LAMEA Apheresis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.4 million by 2028. The Argentina market is estimated to grow at a CAGR of 11.7% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 10.8% during (2022 - 2028).

Based on Procedure, the market is segmented into Donor/Automated and Therapeutic. Based on Product, the market is segmented into Disposable & Reagents, Devices, and Software. Based on Method, the market is segmented into Centrifugation, Membrane Separation, and Selective Adsorption. Based on End User, the market is segmented into Blood Centers, Hospitals, and Others. Based on Component, the market is segmented into Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), and RBC's (Erythropheresis). Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Apheresis Market is Predict to reach $4 Billion by 2028, at a CAGR of 8.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Kaneka Corporation, Cerus Corporation, B. Braun Melsungen AG, Nikkiso Co., Ltd., Charles River Laboratories International, Inc., and SB Kawasumi Laboratories, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Procedure

  • Donor/Automated
  • Therapeutic

By Product

  • Disposable & Reagents
  • Devices
  • Software

By Method

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

By End User

  • Blood Centers
  • Hospitals
  • Others

By Component

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or leukopheresis)
  • Lymphocytes (Lymphopheresis or lymphapheresis)
  • RBC's (Erythropheresis)

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Asahi Kasei Medical Co., Ltd
  • Kaneka Corporation
  • Cerus Corporation
  • B.Braun Melsungen AG
  • Nikkiso Co., Ltd
  • Charles River Laboratories International, Inc.
  • SB Kawasumi Laboratories, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Apheresis Market Report 2022-2028

North America Apheresis Market Report 2022-2028

Asia Pacific Apheresis Market Report 2022-2028

Europe Apheresis Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities